{"id":"https://openalex.org/W2809864758","doi":"https://doi.org/10.1158/1538-7445.am2018-800","title":"Abstract 800: ABBV-744, a first-in-class and highly selective inhibitor of the second bromodomain of BET family proteins, displays robust activities in preclinical models of acute myelogenous leukemia","display_name":"Abstract 800: ABBV-744, a first-in-class and highly selective inhibitor of the second bromodomain of BET family proteins, displays robust activities in preclinical models of acute myelogenous leukemia","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2809864758","doi":"https://doi.org/10.1158/1538-7445.am2018-800","mag":"2809864758"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-800","doi":"https://doi.org/10.1158/1538-7445.am2018-800","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-800","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100445596","display_name":"Xia Li","orcid":"https://orcid.org/0000-0002-9794-2648","observed_orcids":["https://orcid.org/0000-0002-9794-2648","https://orcid.org/0000-0002-4691-4348","https://orcid.org/0000-0002-2991-6544"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoyu Lin","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101601541","display_name":"Xiaoli Huang","orcid":"https://orcid.org/0000-0002-6438-5435","observed_orcids":["https://orcid.org/0000-0002-6438-5435"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoli Huang","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004428348","display_name":"Richard J. Bellin","orcid":"https://orcid.org/0000-0003-1090-0742","observed_orcids":["https://orcid.org/0000-0003-1090-0742"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Bellin","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070247681","display_name":"Emily J. Faivre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Faivre","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070218289","display_name":"Paul Hessler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Hessler","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034213336","display_name":"Lloyd T. Lam","orcid":"https://orcid.org/0000-0002-8252-5753","observed_orcids":["https://orcid.org/0000-0002-8252-5753"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lloyd Lam","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108377141","display_name":"Mai Ha Bui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mai Ha Bui","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112905018","display_name":"Denise M. Wilcox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denise Wilcox","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037648687","display_name":"Tamar Uziel","orcid":"https://orcid.org/0009-0005-8075-1553","observed_orcids":["https://orcid.org/0009-0005-8075-1553"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tamar Uziel","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056984007","display_name":"Debra C. Ferguson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debra C. Ferguson","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044796135","display_name":"Terrance J. Magoc","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terrance J. Magoc","raw_affiliation_strings":["2Abbvie retiree, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Abbvie retiree, IL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021063321","display_name":"Daniel H. Albert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel H. Albert","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036792126","display_name":"Keith F. McDaniel","orcid":"https://orcid.org/0000-0001-5704-3288","observed_orcids":["https://orcid.org/0000-0001-5704-3288"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith F. McDaniel","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074957787","display_name":"Warren M. Kati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Warren Kati","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014176442","display_name":"Yu Shen","orcid":"https://orcid.org/0000-0002-3899-7868","observed_orcids":["https://orcid.org/0000-0002-3899-7868"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Shen","raw_affiliation_strings":["1AbbVie Inc., North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie Inc., North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"800","last_page":"800"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.9100000262260437},{"id":"https://openalex.org/keywords/brd4","display_name":"BRD4","score":0.871999979019165},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.953000009059906},{"id":"https://openalex.org/keywords/abbv-075","display_name":"ABBV-075","score":0.8069999814033508},{"id":"https://openalex.org/keywords/androgen-receptor-positive-prostate-cancer","display_name":"androgen receptor-positive prostate cancer","score":0.8450000286102295},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8410000205039978},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.828000009059906},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.871999979019165},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.7979999780654907},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.6430000066757202},{"id":"https://openalex.org/keywords/epigenetic-therapy","display_name":"epigenetic therapy","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.897470235824585},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6288829445838928},{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.6205962300300598},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5154248476028442},{"id":"https://openalex.org/C2780862049","wikidata":"https://www.wikidata.org/wiki/Q25326844","display_name":"BET inhibitor","level":5,"score":0.45551884174346924},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38199758529663086},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3778766989707947},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.28093546628952026},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.24639892578125},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0994316041469574},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.08975684642791748},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08897492289543152}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-800","doi":"https://doi.org/10.1158/1538-7445.am2018-800","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-800","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3179969410","https://openalex.org/W2922548931","https://openalex.org/W2809823840","https://openalex.org/W2497071632","https://openalex.org/W2485962693","https://openalex.org/W2887270989","https://openalex.org/W2888944824","https://openalex.org/W2987340433","https://openalex.org/W2606852909","https://openalex.org/W2954243543"],"abstract_inverted_index":{"Abstract":[0],"Many":[1],"small-molecule":[2],"inhibitors":[3,35],"that":[4,28,56,62,184,201],"target":[5],"both":[6],"bromodomains":[7,70],"of":[8,38,65,67,87,91,112,130,138,162,231,252,257,304,308,318,325],"the":[9,68,77,88,108,113,127,134,143,188,250,258,305,326],"BET":[10,14,34,72,93,115,150,208,309],"family":[11,73,116,310],"proteins":[12,74],"(pan":[13],"inhibitors)":[15],"are":[16,24,229],"undergoing":[17],"studies":[18],"in":[19,36,51,71,80,158,175,249,315],"clinical":[20,29],"trials.":[21],"Emerging":[22],"data":[23],"beginning":[25],"to":[26,31,53,126,133,142,187],"suggest":[27,200],"responses":[30],"these":[32,198],"pan":[33,92,149],"subsets":[37,83],"hematologic":[39],"malignancies":[40],"may":[41],"be":[42,204],"modest":[43],"and":[44,168,237,255,300],"short":[45],"lived,":[46],"perhaps":[47],"due,":[48],"at":[49],"least":[50],"part,":[52],"tolerability":[54,89],"issues":[55],"limit":[57],"dosing":[58],"levels.":[59],"We":[60],"hypothesized":[61],"selective":[63,105,302],"inhibition":[64],"four":[66,114],"eight":[69],"might":[75],"retain":[76],"anticancer":[78],"activities":[79,146,157,314],"certain":[81],"tumor":[82],"while":[84],"alleviating":[85],"some":[86],"liabilities":[90],"inhibitors,":[94,151],"thus":[95],"possibly":[96],"providing":[97],"better":[98],"therapeutic":[99],"benefits.":[100],"ABBV-744":[101,152,183,202],"is":[102],"a":[103,159,205,298],"highly":[104,301],"inhibitor":[106,190,209,303],"for":[107,182,210,240,329],"second":[109,306],"bromodomain":[110,129,136,307],"(BDII)":[111],"proteins,":[117,311],"exhibiting":[118],"greater":[119],"than":[120],"300-fold":[121],"more":[122],"potent":[123],"binding":[124],"affinity":[125],"BDII":[128],"BRD4":[131],"relative":[132],"first":[135],"(BDI)":[137],"BRD4.":[139],"In":[140],"contrast":[141],"broad":[144],"antiproliferative":[145,156],"observed":[147],"with":[148,193],"only":[153],"displayed":[154],"significant":[155],"limited":[160],"number":[161],"cancer":[163],"cell":[164],"lines,":[165],"including":[166],"AML":[167,176,211],"androgen":[169],"receptor":[170],"(AR)-positive":[171],"prostate":[172],"cancer.":[173],"Studies":[174],"xenograft":[177],"models":[178,317],"demonstrated":[179],"antitumor":[180],"efficacy":[181],"was":[185],"comparable":[186],"pan-BET":[189],"ABBV-075":[191],"but":[192],"improved":[194],"tolerability.":[195],"Taken":[196],"together,":[197],"results":[199],"could":[203],"promising":[206],"second-generation":[207],"therapy.":[212],"Affiliation:":[213],"Oncology":[214],"Discovery,":[215],"AbbVie":[216,247],"Inc.,":[217],"1":[218],"North":[219,222],"Waukegan":[220],"Rd.,":[221],"Chicago,":[223,338],"IL":[224],"60064.":[225],"Disclosures:":[226],"All":[227],"authors":[228],"employees":[230],"AbbVie.":[232,246],"The":[233],"design,":[234],"study":[235],"conduct,":[236],"financial":[238],"support":[239],"this":[241],"research":[242],"were":[243],"provided":[244],"by":[245],"participated":[248],"interpretation":[251],"data,":[253],"review,":[254],"approval":[256],"publication.":[259],"Citation":[260],"Format:":[261],"Xiaoyu":[262],"Lin,":[263],"Xiaoli":[264],"Huang,":[265],"Richard":[266],"Bellin,":[267],"Emily":[268],"Faivre,":[269],"Paul":[270],"Hessler,":[271],"Lloyd":[272],"Lam,":[273],"Mai":[274],"Ha":[275],"Bui,":[276],"Denise":[277],"Wilcox,":[278],"Tamar":[279],"Uziel,":[280],"Debra":[281],"C.":[282],"Ferguson,":[283],"Terrance":[284],"J.":[285],"Magoc,":[286],"Daniel":[287],"H.":[288],"Albert,":[289],"Keith":[290],"F.":[291],"McDaniel,":[292],"Warren":[293],"Kati,":[294],"Yu":[295],"Shen.":[296],"ABBV-744,":[297],"first-in-class":[299],"displays":[312],"robust":[313],"preclinical":[316],"acute":[319],"myelogenous":[320],"leukemia":[321],"[abstract].":[322],"In:":[323],"Proceedings":[324],"American":[327],"Association":[328],"Cancer":[330,343],"Research":[331],"Annual":[332],"Meeting":[333],"2018;":[334],"2018":[335],"Apr":[336],"14-18;":[337],"IL.":[339],"Philadelphia":[340],"(PA):":[341],"AACR;":[342],"Res":[344],"2018;78(13":[345],"Suppl):Abstract":[346],"nr":[347],"800.":[348]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-07-10T00:00:00"}